Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
-
Oct 24, 2013Agenus to host conference call beginning at 11 a.m. ET today
LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (NASDAQ: AGEN), a biotechnology company working to develop novel immunology based treatments for cancers and infectious diseases, today announced its...
-
Oct 16, 2013Agenus to Report Third Quarter 2013 Financial Results on October 24, 2013; Conference Call to Follow
Agenus Inc. (NASDAQ: AGEN) will release its third quarter 2013 financial results before the market opens on October 24, 2013. Agenus executives will host a conference call at 11:00 a.m. Eastern...
-
Oct 7, 2013Significant protection shown 18 months post vaccination
Agenus Inc. (Nasdaq: AGEN) today announced that new Phase 3 data for GlaxoSmithKline’s (NYSE: GSK) RTS,S malaria vaccine candidate, which contains Agenus’ QS-21 Stimulon®1 adjuvant, were...
-
Sep 26, 2013
Agenus Inc. (Nasdaq: AGEN) today announced that it is has entered into a non-exclusive license agreement with VaxLogic, LLC, a subsidiary of PharmLogic LLC, for the use of QS-21 Stimulon®1...
-
Sep 23, 2013
Agenus Inc. (Nasdaq: AGEN) today announced the closing of its previously announced agreement to sell $10 million of shares of its common stock, together with warrants to purchase additional shares...
